Provention Bio, Inc. PRVB
Set alert
At close · Apr 26
52-week range unavailable
- Open
- 24.99
- Prev close
- 24.98
- Mkt cap
- 2.38B
- Vol
- 9.12M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 24.98
- High
- 25.00
- Forward P/E
- -192.15
- Beta
- 2.46
- Short ratio
- 1.53
- Inst. own
- 53.26%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 4, 2023
- 50-d avg
- 19.10
- 200-d avg
- 10.15
- 1y target
- 23.50
News
3 years ago globenewswire.com
Press Release: Hart-Scott-Rodino waiting period expires for Sanofi's acquisition of Provention Bio, Inc.
Hart-Scott- Rodino waiting period expires for Sanofi's acquisition of Provention Bio, Inc. Paris, France – April 26 , 2023 – Sanofi announced today that the waiting period under the Hart-Scott-Rodino…
3 years ago 247wallst.com
The 5 Best- and Worst-Performing Mid-Cap Stocks in March 2023
March was a good month for the stock market, with the S&P 500 gaining about 3.5%.
3 years ago businesswire.com
PROVENTION BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Provention Bio, Inc. - PRVB
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Provention Bio,…
3 years ago fool.com
Why Provention Bio Stock Skyrocketed 256% This Week
Sanofi plans to acquire Provention Bio for around $2.9 billion. The deal will add Provention's type 1 diabetes drug Tzield to Sanofi's lineup.
-
3 years ago benzinga.com
Earnings Scheduled For March 16, 2023
Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly earnings at $0.03 per share on revenue of $34.29 million.
3 years ago zacks.com
Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi
Provention Bio (PRVB) to be acquired by pharma-giant Sanofi (SNY) for $2.9 billion. The transaction is likely to close by second-quarter 2023.
3 years ago prnewswire.com
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Provention Bio, Inc. - PRVB
NEW YORK , March 14, 2023 /PRNewswire/ -- Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm…
3 years ago invezz.com
This biopharma stock jumped over 250% on Monday: what happened?
Shares of Provention Bio Inc (NASDAQ: PRVB) more than tripled on Monday after Sanofi S.A. (EPA: SAN) confirmed plans of buying the biopharmaceutical company that focused on autoimmune diseases.
3 years ago fool.com
Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners
Markets were mixed on a volatile day on Wall Street. Sanofi offered to buy Provention Bio at a price more than triple where the stock closed Friday.
-
3 years ago benzinga.com
Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.
3 years ago prnewswire.com
Shareholder Alert: Ademi LLP investigates whether Provention Bio, Inc. has obtained a Fair Price in its transaction with Sanofi
MILWAUKEE , March 13, 2023 /PRNewswire/ -- Ademi LLP is investigating Provention Bio (Nasdaq: PRVB) for possible breaches of fiduciary duty and other violations of law in its transaction with Sanofi.…
3 years ago marketwatch.com
Regional banks pace decliners, as biotech deals lift Seagen and Provention Bio
Here are some of the biggest movers on Monday with banks firmly in focus after federal regulators stepped into protect deposits at fallen bank SVB.
-
3 years ago benzinga.com
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.
3 years ago proactiveinvestors.com
Provention Bio shares soar after Sanofi agrees to buy company in $2.9B cash deal
French drugmaker Sanofi has announced an agreement to acquire US-based biopharmaceutical company Provention Bio Inc (NASDAQ:PRVB), which focuses on autoimmune diseases, for $25 per share in cash, or…
3 years ago businesswire.com
PRVB STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Provention Bio, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Provention Bio, Inc. (NASDAQ: PRVB) to Sanofi for $25.00 per share in cash is fair to…
3 years ago investorplace.com
Why Is Provention Bio (PRVB) Stock Up 263% Today?
Provention Bio (NASDAQ: PRVB ) stock is rocketing higher on Monday following news that Sanofi (NASDAQ: SNY ) is acquiring the company. That deal has Sanofi agreeing to acquire Provention Bio for $25…
3 years ago prnewswire.com
Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
RED BANK, N.J. , March 13, 2023 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced it…
3 years ago pulse2.com
Sanofi To Buy Provention Bio In $2.9 Billion Deal (SNY) (PRVB)
Sanofi (NASDAQ: SNY) announced it is buying Provention Bio (NASDAQ: PRVB) as part of a $2.9 billion deal. These are the details.
3 years ago marketwatch.com
Sanofi to buy Provention Bio in deal worth $2.9 billion
French pharmaceutical group Sanofi said Monday that it will buy Provention Bio, Inc., a U.S.-based biopharmaceutical company focused on autoimmune diseases, for $25 per share in cash, in a deal with…
3 years ago globenewswire.com
Press Release: Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D)
Sanofi to acquire Proventio n Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D)
3 years ago prnewswire.com
Provention Bio Announces the Grant of Inducement Awards
RED BANK, N.J. , March 3, 2023 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases,…
3 years ago prnewswire.com
Provention Bio to Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023
RED BANK, N.J. , Feb. 23, 2023 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases,…
3 years ago seekingalpha.com
Provention Bio: Good Prospects In Type 1 Diabetes, But Patent Protection Is A Worry
PRVB got its teplizumab approved last year. The molecule is a wonderful new addition to T1D therapy; however, it has been in development for decades.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 68 companies reached new 52-week highs.
-
3 years ago benzinga.com
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
-
4 years ago benzinga.com
Earnings Scheduled For August 4, 2022
Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 539 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning trading, 400 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
-
4 years ago benzinga.com
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
-
5 years ago benzinga.com
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
-
5 years ago benzinga.com
54 Biggest Movers From Yesterday
Gainers Flanigan's Enterprises, Inc. (NYSE: BDL) shares surged 40.6% to close at $34.90 on Tuesday after the company reported results for the 13 weeks and the 26 weeks ended April 3, 2021.
-
5 years ago benzinga.com
42 Stocks Moving In Tuesday's Mid-Day Session
Gainers SemiLEDs Corporation (NASDAQ: LEDS) shares surged 28.4% to $10.17 following reports indicating equipment billings increased 50% in April compared to the prior year's period.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows.
-
5 years ago benzinga.com
Earnings Scheduled For May 6, 2021
Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.
-
5 years ago benzinga.com
Mid-Morning Market Update: Markets Open Higher; US Producer Prices Rise 1% In March
Following the market opening Friday, the Dow traded up 0.29% to 33,487.00 while the NASDAQ rose 0.01% to 13,748.50. The S&P also rose, gaining 0.21% to 4,097.50.
-
5 years ago benzinga.com
80 Biggest Movers From Yesterday
Gainers Live Ventures Incorporated (NASDAQ: LIVE) shares jumped 90.4% to close at $23.90 on Wednesday after the company swung to a profit in the fourth quarter.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
On Tuesday morning, 323 companies hit new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
Monday's morning session saw 240 companies set new 52-week highs.
-
5 years ago benzinga.com
Earnings Scheduled For November 5, 2020
Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is expected to report quarterly loss at $0.64 per share on revenue of $52.59 million.
-
6 years ago benzinga.com
96 Biggest Movers From Friday
Gainers Fuel Tech, Inc (NASDAQ: FTEK) shares climbed 93.6% to close at $0.91 on Friday after the company reported FUEL CHEM® demonstration orders from two new industrial power customers.
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Mon., Dec. 3, 2018
Stocks Which Set New 52-Week Low Yesterday, Mon., Dec. 3, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018
Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 26, 2018
Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 26, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low The Prior Trading Session, Fri., Nov. 23, 2018
Stocks Which Set New 52-Week Low The Prior Trading Session, Fri., Nov. 23, 2018